For clinical professionals, Renovó offers a range of high-potency exosome formulations, including options with up to 180 billion exosomes per treatment. Here’s why Wharton’s Jelly exosomes are superior to other regenerative options:
• PRP and Platelets: While PRP treatments rely on growth factors found in your blood, they are far less potent than exosomes. PRP does not contain the same variety of regenerative signals as exosomes, making it less effective in promoting hair growth.
• Adipose & Bone Marrow Stem Cells: Exosomes derived from fat or bone marrow stem cells come from older, less efficient tissues. Wharton’s Jelly-derived exosomes, being from a younger source, are more effective in regenerating damaged or dormant hair follicles.
• Placenta & Amniotic Fluid: While placenta-derived exosomes are used in some treatments, they lack the regenerative signaling power of Wharton’s Jelly MSC exosomes. Placental cells, being older, don’t match the regenerative capacity of umbilical-derived sources.
Unlike hair transplants, which merely relocate existing hair follicles and require invasive surgery, exosome therapy addresses the root of hair loss by regenerating and revitalizing existing follicles. Transplants often result in unnatural hairlines, take time to recover from, and don’t prevent future hair loss—exosome therapy offers a longer-term, natural, and more effective solution.